ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every Mangalam Drugs and Organics financial results announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Mangalam Drugs and Organics Ltd reported revenue from operations of ₹79.4 Cr (+61.1% YoY) and a net loss of ₹7.2 Cr for Q2 FY27.
Mangalam Drugs and Organics Ltd reported revenue from operations of ₹57.1 Cr (-0.2% YoY) and a net loss of ₹7.6 Cr for Q1 FY27.
Mangalam Drugs and Organics Ltd reported revenue from operations of ₹67.3 Cr (-7.6% YoY) and a net loss of ₹13.4 Cr for Q4 FY26.
Mangalam Drugs & Organics Ltd reported its audited standalone and consolidated financial results for the year ended March 31, 2026. The Board approved the audited performance today.